The lung pathology seen in patients with coronavirus disease 2019 (COVID-19) shows
marked microvascular thrombosis and haemorrhage linked to extensive alveolar and …

With the expanding use of molecular assays, viral pathogens are increasingly recognized
among critically ill adult patients with community-acquired severe respiratory illness; studies …

Background The ongoing pandemic of Novel Coronavirus Disease 2019 (COVID-19)
infection has created a global emergency. Despite the infection causes a mild illness to most …

Background Cardiac injury is now a common complication of coronavirus disease (COVID-
19), but it remains unclear whether cardiac injury-related biomarkers can be independent …

Background Due to the overlapping clinical features of coronavirus disease 2019 (COVID-
19) and influenza, parallels are often drawn between the two diseases. Patients with pre …

Objectives: To evaluate the prevalence of cardiac injury and its association with mortality in
hospitalized patients infected with avian influenza A (H7N9) virus. Design: Retrospective …

OBJECTIVES: Severe acute respiratory syndrome–related coronavirus-2 binds and inhibits
angiotensin-converting enzyme-2. The frequency of acute cardiac injury in patients with …

Fulminant myocarditis is a clinical syndrome with signs of acute heart failure, cardiogenic
shock, or life-threating rhythm disturbances in the context of suspected myocarditis. It is not …

There has been strong evidence of myocardial injury in COVID-19 patients with significantly
elevated serum cardiac troponin (cTn). While the exact mechanism of injury is unclear …

Background There are inconsistent data on the clinical benefit of the influenza vaccine on
cardiovascular outcomes in patients with coronary artery disease (CAD). Therefore, the aim …